Bevacizumab
安维汀(Avastin)
The original anti-angiogenesis antibody — starves tumors of blood supply. Many cheap biosimilars in China.
At a glance
China price
Verified pricing is not currently available.
NRDL (national insurance)
In NRDL; multiple biosimilars at low prices.
Regulatory status
NMPA approved (2010); NRDL (2017)
What this meansSupported by a credible secondary source but not yet independently confirmed against a primary source.
SourceNo independent source on file.
NotesApproval status from public regulatory reporting.
What it treats
Colorectal, lung, liver, ovarian, cervical cancers and glioblastoma per label.
Sources & verification
No independent source is currently on file. We have not independently verified this information.
Reader discussion
Public comments about Bevacizumab. Discussion is not medical advice, and a comment is not an endorsement or a verified fact. Open the full forum.